Medtronic's Q2 Earnings & Revenues Beat Estimates, Stock Climbs

Key Takeaways Medtronic's Q2 EPS of $1.36 and $8.96B in revenues beat estimates and grew year over year.MDT's Cardiovascular segment rose 9.3% organically, led by strong Cardiac Rhythm & Heart Failure sales.Medtronic raised its fiscal 2026 organic revenue and full-year adjusted EPS guidance.Medtronic plc (MDT) reported second-quarter fiscal 2026 adjusted earnings per share (EPS) of $1.36, which rose 7.9% from the year-ago quarter’s figure and beat the Zacks Consensus Estimate by 3.82%.Without certain one-ti ...